CytRx Corp. buy melinda
Start price
13.06.17
/
50%
€3.13
Target price
22.06.17
€3.79
Performance (%)
21.80%
End price
22.06.17
€3.82
Summary
This prediction ended on 22.06.17 with a price of €3.82. The prediction had a final performance of 21.80%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
CytRx Corp. | - | - | - | - |
iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
(Zielkurs erreicht)